Samantha Barry
Family · Jacksonville, FLNPI 1023515418
Payments from drug & device makers
Across 250 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$580
- Antares Pharma, Inc.$540
- Novo Nordisk$451
- Lilly USA, LLC$362
- Amgen$290
- Boehringer Ingelheim$181
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,631100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $580 |
| Antares Pharma, Inc. | 24 | $540 |
| Novo Nordisk | 35 | $451 |
| Lilly USA, LLC | 22 | $362 |
| Amgen | 17 | $290 |
| Boehringer Ingelheim | 10 | $181 |
| Corcept Therapeutics | 8 | $161 |
| Medtronic | 1 | $135 |
| Novartis | 7 | $131 |
| Abbott | 6 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Neos Therapeutics, LP | 7 | $107 |
| Corium, LLC | 5 | $107 |
| Bayer | 5 | $101 |
| Idorsia Pharmaceuticals US Inc | 5 | $97 |
| Exact Sciences | 5 | $93 |
| Clarus Therapeutics Inc. | 10 | $89 |
| Tris Pharma Inc | 4 | $84 |
| Halozyme Inc | 4 | $82 |
| GSK | 3 | $70 |
| Optinose US, Inc. | 3 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $55 |
| Tolmar, Inc. | 3 | $52 |
| Vivus LLC | 3 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Pfizer | 2 | $42 |
| Lucid Diagnostics Inc. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Merck | 2 | $39 |
| Eisai Inc. | 3 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $34 |
| Acerus Pharmaceuticals Corporation | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Johnson & Johnson | 1 | $26 |
| Philips North America LLC | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $16 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$135
- FARXIGA$122
How this compares
$4,638 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $18,566 |
| Ezetimibe | 13 | $765 |
| Rosuvastatin Calcium | 59 | $541 |
| Atorvastatin Calcium | 57 | $461 |
| Metoprolol Succinate | 25 | $400 |
| Losartan Potassium | 30 | $370 |
| Omeprazole | 28 | $369 |
| Levothyroxine Sodium | 30 | $367 |
| Bupropion XlBupropion Hcl | 14 | $287 |
| Amlodipine Besylate | 48 | $245 |
| Tamsulosin Hcl | 17 | $234 |
| Montelukast Sodium | 19 | $207 |
| Escitalopram Oxalate | 20 | $195 |
| Sertraline Hcl | 16 | $183 |
| Metformin Hcl | 33 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $181 | $18,56615 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $18316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Jacksonville
- Leighanne MeadeJacksonville$98K
- Jori TaylorJacksonville$48K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.